{"entity":{"type":"insider","cik":"0001251781","url":"/insider/0001251781","json_url":"/insider/0001251781.json","name":"BRANDT GORDON","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":13,"first":"2006-03-28","last":"2007-04-24","span_basis":"filed_date"},"name_variants":[{"name":"BRANDT GORDON","source":"filing","n_filings":13,"first_seen":"2006-03-28","last_seen":"2007-04-24"}],"transactions":[{"id":7238637,"accession":"0001209191-07-025228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-025228","line_url":"/filing/0001209191-07-025228#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.2218,"price_display":"13.22","price_state":"stated","total_value":66109.0,"total_display":"66,109.00","total_whole":"66,109","shares_owned_after":23165.0,"shares_owned_after_display":"23,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-20","filed_date":"2007-04-24","scope":"insider"},{"id":7579576,"accession":"0001209191-07-008727","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-008727","line_url":"/filing/0001209191-07-008727#line-4","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.1192,"price_display":"13.12","price_state":"stated","total_value":65596.0,"total_display":"65,596.00","total_whole":"65,596","shares_owned_after":23165.0,"shares_owned_after_display":"23,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-07","filed_date":"2007-02-08","scope":"insider"},{"id":7613087,"accession":"0001209191-07-002457","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-002457","line_url":"/filing/0001209191-07-002457#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.6938,"price_display":"14.69","price_state":"stated","total_value":73469.0,"total_display":"73,469.00","total_whole":"73,469","shares_owned_after":11825.0,"shares_owned_after_display":"11,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-01-04","filed_date":"2007-01-05","scope":"insider"},{"id":3818325,"accession":"0001209191-06-066821","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-066821","line_url":"/filing/0001209191-06-066821#line-1","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":675.0,"shares_display":"675","price_per_share":15.67,"price_display":"15.67","price_state":"stated","total_value":10577.25,"total_display":"10,577.25","total_whole":"10,577","shares_owned_after":11825.0,"shares_owned_after_display":"11,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-22","filed_date":"2006-12-22","scope":"insider"},{"id":3395203,"accession":"0001209191-06-063563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-063563","line_url":"/filing/0001209191-06-063563#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.1825,"price_display":"16.18","price_state":"stated","total_value":80912.5,"total_display":"80,912.50","total_whole":"80,913","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-05","filed_date":"2006-12-07","scope":"insider"},{"id":5428958,"accession":"0001209191-06-057725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-057725","line_url":"/filing/0001209191-06-057725#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.4526,"price_display":"16.45","price_state":"stated","total_value":82263.0,"total_display":"82,263.00","total_whole":"82,263","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-11-03","filed_date":"2006-11-03","scope":"insider"},{"id":5428319,"accession":"0001209191-06-053861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-053861","line_url":"/filing/0001209191-06-053861#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.1418,"price_display":"15.14","price_state":"stated","total_value":75709.0,"total_display":"75,709.00","total_whole":"75,709","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-04","filed_date":"2006-10-05","scope":"insider"},{"id":3553218,"accession":"0001209191-06-049263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-049263","line_url":"/filing/0001209191-06-049263#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.1042,"price_display":"15.10","price_state":"stated","total_value":75521.0,"total_display":"75,521.00","total_whole":"75,521","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-09-06","filed_date":"2006-09-07","scope":"insider"},{"id":3813805,"accession":"0001209191-06-044537","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-06-044537","line_url":"/filing/0001209191-06-044537#line-4","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.8526,"price_display":"13.85","price_state":"stated","total_value":69263.0,"total_display":"69,263.00","total_whole":"69,263","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-03","filed_date":"2006-08-04","scope":"insider"},{"id":4016612,"accession":"0001209191-06-040268","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-040268","line_url":"/filing/0001209191-06-040268#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.4251,"price_display":"15.43","price_state":"stated","total_value":77125.5,"total_display":"77,125.50","total_whole":"77,126","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-06","filed_date":"2006-07-06","scope":"insider"},{"id":3931615,"accession":"0001209191-06-034683","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-034683","line_url":"/filing/0001209191-06-034683#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.8091,"price_display":"14.81","price_state":"stated","total_value":74045.5,"total_display":"74,045.50","total_whole":"74,046","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-06-05","filed_date":"2006-06-05","scope":"insider"},{"id":3845333,"accession":"0001209191-06-030014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-030014","line_url":"/filing/0001209191-06-030014#line-2","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Company Inc Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.5702,"price_display":"14.57","price_state":"stated","total_value":72851.0,"total_display":"72,851.00","total_whole":"72,851","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-11","filed_date":"2006-05-15","scope":"insider"},{"id":3949735,"accession":"0001209191-06-020245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-020245","line_url":"/filing/0001209191-06-020245#line-1","is_derivative":false,"issuer_cik":"0000737207","issuer_name":"NASTECH PHARMACEUTICAL CO INC","issuer_ticker":"NSTK","issuer_name_source":null,"issuer_url":"/issuer/0000737207","owner_cik":"0001251781","owner_name":"BRANDT GORDON","owner_display_name":"BRANDT GORDON","owner_url":"/insider/0001251781","role":"Officer (Exec VP of Science and Clinica)","role_mark":"O","role_mark_label":"Officer (Exec VP of Science and Clinica)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec VP of Science and Clinica","security_title":"Nastech Pharmaceutical Co. Inc. Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1685.0,"shares_display":"1,685","price_per_share":18.34,"price_display":"18.34","price_state":"stated","total_value":30902.9,"total_display":"30,902.90","total_whole":"30,903","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-27","filed_date":"2006-03-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000737207","name":"NASTECH PHARMACEUTICAL CO INC","url":"/issuer/0000737207","role":"Officer (Exec VP of Science and Clinica)","n_filings":13,"first_seen":"2006-03-28","last_seen":"2007-04-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001251781","retrieved_at":"2026-08-27T19:13:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}